Close

Tonix Pharma (TNXP) Announces New Data from TNX-102 SL Phase 2 in PTSD

December 8, 2016 7:06 AM EST Send to a Friend
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) recently presented new results from a sub-group analysis of the data from the AtEase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login